Dalbotten v. C R Bard Incorporated

District Court, D. Montana·Decided January 27, 2023·No. 1:20-cv-00034·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MONTANA BILLINGS DIVISION

- MARIA DALBOTTEN, Case No. 1:20-cv-00034-SPW Plaintiff, ORDER ON DEFENDANTS’ y MOTION TO EXCLUDE OR LIMIT OPINIONS AND C. R. BARD, INC. and BARD TESTIMONY OF DEREK PERIPHERAL VASCULAR, INC., | MUEHRCKE, M.D.

Defendants.

Before the Court is Defendants C.R. Bard, Inc. and Bard Peripheral Vascular, Inc.’s Motion to Exclude or Limit Opinions and Testimony of Derek Muehrcke, M.D. (Doc. 104). Defendants seek to exclude. Dr. Muehrcke from testifying in several areas. (Doc. 110 at 9-10).' A large portion of the motion is identical to issues previously addressed by the MDL Court. (See Doc. 110-2). The Court adopts those holdings from the MDL Court and grants in part and denies in part the Defendants’ motion for the following reasons. I. Background Dr. Muehrcke is a cardiothoracic surgeon who received his specialty training at Harvard Medical School and Massachusetts General Hospital. (Doc. 97-9 at 3).

' For consistency, the Court will cite to the page numbers generated by CM/ECF rather than those provided by the parties themselves.

As stated in his report, Dr. Muehrcke practices as part of a private medical group that performs heart surgeries at several hospitals and also serves as the Chief of Cardiothoracic Surgery at Flager Hospital in Saint Augustine, Florida. He states that he has more than 20 years of experience treating patients with IVC heart filters. He has implanted and removed every iteration of Bard’s filters over that period. He has implanted hundreds of filters and has removed entire filters and fragments from the heart. Defendants seek to exclude 15 areas of inquiry.” Six of these areas were addressed by the MDL court. The 15 areas are: 1. Whether the G2 filter is unreasonably dangerous or defective; 2. Whether the dangers of the G2 filter outweighed the potential benefits; 3. The presence of design defects and alternate filter designs; 4. Personal opinions or judgments about Bard’s internal documents; 5. The standard of care of a reasonable device manufacturer; 6. Characterization and actions of physicians generally; 7. Bard’s motive and intentions; 8. Sufficiency of the G2 filter’s Instructions for Use (“IFU”); 9. Adequacy of the warnings Bard provided regarding the G2 filter; 10.Whether Bard’s marketing information was false or misleading; 11.Whether and how Plaintiff's G2 filter failed; Whether the failure of Plaintiffs filter necessitated surgery; 13.Whether Plaintiff suffered pain and anxiety; 14.Future recommendations for Plaintiff; 15.Adoption or reliance on other expert opinions. (Doc. 110 at 9-10).

? These 15 specific areas do not correspond precisely with the arguments presented by Defendants in the body of the brief in support of the motion. Some are addressed out of order and others do not appear to be addressed at all beyond the introduction. Nonetheless, the Court has attempted to fully address each specific issue.

II. Legal Standard Under Federal Rule of Evidence 702, a properly qualified expert may testify on the basis of scientific, technical, or other specialized knowledge if it will assist the trier of fact to understand the evidence. An expert is properly qualified based

on their “knowledge, skill, experience, training, or education.” Fed. R. Evid. 702(a)-(d). The testimony must rest on sufficient facts and data, be based on reliable principles and methods, and the expert must reliably apply the principles and methods to the facts of the case. /d.; Daubert v. Merrell Dow Pharm., Inc., 509 U.S. 579, 597 (1993). However, cross-examination, rather than exclusion, is the traditional and appropriate method for addressing shaky but admissible evidence. Daubert, 509 U.S. at 596. Ill. Analysis A. Whether the G2 Filter is “defective” or “unreasonably dangerous” Defendants move to preclude Dr. Muehrcke from testifying that the G2 Filter was unreasonably dangerous or defective, on the grounds that such testimony constitutes a legal opinion. (Doc. 110 at 24). However, testimony is not objectionable merely because it embraces an ultimate issue. Fed. R. Evid. 704. Dr. Muehrcke’s proffered opinion is that he believes the risks posed by the G2 Filter outweighed its benefits and that the filter suffered from several defects.

Whether a product is ultimately defective under Montana law is a question solely for the jury, but an expert is permitted to testify that the filter suffered from several flaws and that, in his opinion, the risks outweighed the benefits without that testimony constituting a legal opinion. The motion is denied as to this issue. B. Whether the risks of the filter outweigh the benefits Similarly, Defendants seek to limit Dr. Muehrcke from testifying that the dangers of the filter outweighed the benefits at the time of its implantation. (Doc. 110 at 9). Depending on the foundation laid at trial for this testimony, such an opinion may be permissible. Dr. Muehrcke is an experienced cardiothoracic

surgeon and is therefore qualified to offer opinions as to the risks and benefits of certain procedures. If he provides sufficient support for his conclusions and relies

upon admissible information, testimony regarding the risks and benefits of the G2 filter may be appropriate. The Court will reserve ruling on this issue until trial. C. Design defects, iterations, and design history Defendants move to limit Muerhcke from testifying or opining on the design of IVC filters and the G2 filter. (Doc. 110 at 22). They argue that he has no expertise to offer such opinions and he is not an expert in filter design. Jd. The Court agrees that Dr. Muehrcke may not testify as an engineer or design expert as to structural design weaknesses of the G2 filter. However, as a cardiothoracic

surgeon who has implanted and removed hundreds of IVC filters in his career, he

is clearly qualified to opine on factors potentially causing a filter’s failure, such as

a lack of migration resistance. Judge Campbell in the MDL came to the same conclusion. Dr. Muehrcke may also be qualified to opine on more specific design problems such as inadequate leg span, lack of strength and stability, or lack of radial force, depending on the foundation laid for that testimony, including his medical training and experience in implanting and removing IVC filters. Accordingly, as to this issue, the Court defers ruling. D. Personal opinions that he was “alarmed” or “disturbed” by Bard’s conduct and/or internal documents Plaintiff agrees not to elicit this testimony. (Doc. 142 at 16). Accordingly, the motion is granted as to this issue. E. Standard of care of a reasonable device manufacturer Defendants do not elaborate on their assertion that Dr. Muehrcke be barred from testifying as to the standard of care of a reasonable device manufacturer, beyond listing it as a specific opinion to be excluded. Dr. Muehrcke is not an expert in device manufacture and therefore, absent foundation to the contrary, the Court grants the motion as to this issue. F. Characterization and actions of physicians generally Defendants seek to limit Dr. Muehrcke from characterization of actions of physicians and specifically limit his use of the phrase, “physicians such as myself.”

(Doc. 110 at 9). The basis for this argument is totally unexplained. Dr. Muehrcke is a cardiothoracic surgeon and is certainly qualified to explain what he or other physicians might expect. The motion is denied on this issue. G.

Free access — add to your briefcase to read the full text and ask questions with AI

Dalbotten v. C R Bard Incorporated, (D. Mont. 2023).

Dalbotten v. C R Bard Incorporated (Dalbotten v. C R Bard Incorporated) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)